Sign inJoin waitlistJoin the waitlist

Rafi Kazi

Fellowship Associate Director · University of Rochester Medicine

Credentials: · · ·

History

University of Rochester Medicine
Present

Pediatric Hematology-Oncology
Emory University Hospital.
2017–2018
Pediatrics
Strong Memorial Hospital/University of Rochester.
2014–2017
Univ of Arkansas Coll of Med
2010–2014

Research

Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor
Vascular Medicine · 2005 · 43 citations
Identification of a homocysteine receptor in the peripheral endothelium and its role in proliferation
Journal of Vascular Surgery · 2005 · 33 citations
Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein
Review · Oncology Reviews · 2024 · 8 citations

Daniel Wechsler
2 papers · 1 as a fellow
HC
Hongjiang Chen
2 papers
IQ
Irfan Qureshi
2 papers · 2 as a resident
John Eidt
2 papers
Mohammed Moursi
2 papers
RF
Ryan Fitzgerald
2 papers
WA
Waitman Aumann
2 papers
Amanda Harrington
1 paper
Jessica Heath
1 paper
John Cooke
1 paper
PM
Perkins Mukunyadzi
1 paper
Sei Sze
1 paper

Clinical trials

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030